August 2019//Funding



Synendos receives a co-fund by the European Union as part of the SME Instrument phase 1 (Horizon2020) to contribute to the translation of our preclinical programme into clinical development.

© 2019 Synendos Therapeutics, Inc. All Rights Reserved.

  • LinkedIn - cerchio grigio
  • Twitter - cerchio grigio